New web tool aims to simplify genetic testing decisions for prostate cancer patients

NCT ID NCT04447703

Completed Knowledge-focused Sponsor: Thomas Jefferson University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a mobile-friendly web tool that educates men with prostate cancer about genetic testing. Researchers compared traditional genetic counseling with the online tool to see if it helps patients decide whether to get tested. The study involved 346 men with advanced or high-risk prostate cancer.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: web-based genetic education tool and genetic counseling
What this could lead to: If successful, this could make genetic testing information more accessible for men with prostate cancer, helping them make informed decisions.
What could go wrong: This is a completed study focused on user testing and decision-making, not on treatment outcomes. The tool may not change actual testing rates or health results.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BIOCHEMICALLY RECURRENT PROSTATE CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

metastatic prostate carcinoma prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BIOCHEMICALLY RECURRENT PROSTATE CARCINOMA METASTATIC PROSTATE CARCINOMA STAGE IIIB PROSTATE CANCER AJCC V8 STAGE IIIC PROSTATE CANCER AJCC V8 STAGE IV PROSTATE CANCER AJCC V8

Contacts and locations

Locations

Associated Medical Professions of New York

Syracuse, New York, 13210, United States
New York University- Langone Health

New York, New York, 10016, United States
Sidney Kimmel Cancer Center at Thomas Jefferson University

Philadelphia, Pennsylvania, 19107, United States
University of Washington/ SCCA

Seattle, Washington, 98109, United States
VA New York Harbor Health System- Manhattan Campus

New York, New York, 10010, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.